Hercessi Prices, Coupons, Copay Cards & Patient Assistance
Hercessi (trastuzumab) is a member of the HER2 inhibitors drug class and is commonly used for Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, and others.
The cost for Hercessi strf 150 mg intravenous powder for injection is around $1,422 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Hercessi prices
Intravenous Powder For Injection
strf 150 mg
Hercessi intravenous powder for injection
from $1,422.33
for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $1,422.33 | $1,422.33 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
strf 420 mg
Hercessi intravenous powder for injection
from $3,964.52
for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $3,964.52 | $3,964.52 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Hercessi Coupons, Copay Cards and Rebates
Hercessi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
No manufacturer promotions could be found for this medication.
Patient Assistance & Copay Programs for Hercessi
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Hercessi (trastuzumab-strf) Injection for Intravenous use
More information please phone: 866-316-7263 Visit Website
Provider: AccordCares: Hercessi
Eligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- Based on FPL
- FDA-approved diagnosis
- Must be US citizen or permanent resident residing in the US or US territories and treated by a US licensed doctor.
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
- Hercessi (trastuzumab-strf) Injection for Intravenous use
More information please phone: 866-258-7151 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Docetaxel
Docetaxel systemic is used for breast cancer, breast cancer, metastatic, gastric cancer, head and ...
More about Hercessi (trastuzumab)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Herceptin, Trazimera, Ontruzant, Kanjinti, ... +2 more
Professional resources
Other brands
Herceptin, Trazimera, Ontruzant, Kanjinti, ... +2 more
